Page last updated: 2024-09-04

cyc 202 and Sclerosis, Systemic

cyc 202 has been researched along with Sclerosis, Systemic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Feghali-Bostwick, CA; Robinson, AR; Steinman, RA	1

Other Studies

1 other study(ies) available for cyc 202 and Sclerosis, Systemic

Article	Year
Antifibrotic effects of roscovitine in normal and scleroderma fibroblasts. PloS one, 2012, Volume: 7, Issue:11 Topics: Animals; Collagen; Connective Tissue Growth Factor; Fibroblasts; Fibronectins; Fibrosis; Humans; Interleukin-6; Mice; NIH 3T3 Cells; Phosphorylation; Purines; Roscovitine; Scleroderma, Systemic; Signal Transduction; STAT3 Transcription Factor; Transcription, Genetic; Transforming Growth Factor beta; Up-Regulation	2012

Article

Year

Antifibrotic effects of roscovitine in normal and scleroderma fibroblasts.

PloS one, 2012, Volume: 7, Issue:11

Topics: Animals; Collagen; Connective Tissue Growth Factor; Fibroblasts; Fibronectins; Fibrosis; Humans; Interleukin-6; Mice; NIH 3T3 Cells; Phosphorylation; Purines; Roscovitine; Scleroderma, Systemic; Signal Transduction; STAT3 Transcription Factor; Transcription, Genetic; Transforming Growth Factor beta; Up-Regulation

2012